U.S. Construction Stock News

NasdaqGS:CGON
NasdaqGS:CGONBiotechs

CG Oncology (CGON) Faces A Fair Value Gap Following Its Latest Earnings

What CG Oncology’s Latest Earnings Tell You About the Business CG Oncology (CGON) recently posted second quarter and first half 2026 results, giving investors fresh detail on how revenue and losses are tracking for this late stage bladder cancer focused biotech. For the quarter ended June 30, 2026, CG Oncology reported revenue of US$1.16 million. The company recorded a net loss of US$79.06 million and a basic loss per share from continuing operations of US$0.90. For the first six months of...
NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

Phibro Animal Health (PAHC) Stock Looks Undervalued On Earnings Yet Mixed Elsewhere

Phibro Animal Health has delivered a strong 139.6% return over the past three years, yet its current valuation checks offer a more restrained read on how cheap the stock really is today. Phibro Animal Health's share price is up 139.6% over three years, which puts extra focus on whether the current level is already baking in much of the improvement investors were looking for. Future expectations for the company’s animal health portfolio can support the current price, while any pressure on...
NasdaqGS:MYRG
NasdaqGS:MYRGConstruction

Does MYR Group’s Acquisition Push, Funded by MYRG’s Balance Sheet, Deepen the Long-Term Infrastructure Story?

In its second-quarter 2026 earnings call, MYR Group highlighted strong results and reiterated that existing credit capacity and operating cash flow should support organic expansion, potential acquisitions, and opportunistic share repurchases. This focus on acquisitions and capital deployment underscores management’s confidence in sustained demand for electrical infrastructure tied to grid upgrades, electrification, renewables integration, and AI-driven data center projects. We’ll now...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

Why 10x Genomics (TXG) Is Up 21.7% After Raising 2026 Outlook Despite Q2 Revenue Drop

In August 2026, 10x Genomics, Inc. reported that second-quarter revenue fell to US$151.04 million from US$172.91 million a year earlier, moving from net income of US$34.54 million to a net loss of US$17.93 million, but simultaneously raised its full-year 2026 revenue guidance to US$610 million–US$630 million from US$600 million–US$625 million. This combination of weaker recent results and a slightly higher full-year outlook highlights a tension between current operating pressure and...
NYSE:DINO
NYSE:DINOOil and Gas

Is HF Sinclair (DINO) Fully Valued As New Base Oil Deals Lift Its Outlook?

HF Sinclair (DINO) is drawing fresh attention after being highlighted as a value stock and announcing new long-term base oil supply and distribution agreements with SK Enmove and Chevron across North America. See our latest analysis for HF Sinclair. For HF Sinclair, these new base oil agreements arrive alongside strong price momentum, with the share price at $87.93 and a year to date share price return of 87.68% and a 1 year total shareholder return of 103.69%. This suggests that investors...
NYSE:CRC
NYSE:CRCOil and Gas

CRC’s Q2 Earnings, Buybacks and CCS Progress Might Change The Case For Investing In California Resources (CRC)

California Resources Corporation recently reported past second-quarter 2026 results, with revenue of US$1,297 million and net income of US$514 million, while affirming production guidance, completing a large share repurchase program, and declaring a quarterly dividend of US$0.405 per share. Together with advancing California’s first commercial carbon capture and storage project and acquiring Crimson Midstream’s pipeline network, these updates reinforce CRC’s integrated model combining oil...
NYSE:RCL
NYSE:RCLHospitality

Carnival Stock And 2 US Cruise Operators Riding Lower Fuel Costs

Cooling inflation, cheaper gas and a less aggressive Federal Reserve have put fuel sensitive travel and leisure stocks back in the spotlight, just as many consumers rethink how they spend on getaways and experiences. This mix of relief and uncertainty can create pockets of opportunity and risk. This article walks through three U.S. Fuel Sensitive Travel and Leisure Operators from our screener that appear especially exposed to these cross currents right now. The stocks covered below are only a...
NYSE:COF
NYSE:COFConsumer Finance

Will Capital One’s 20-Year Arena Deal and Cardholder Perks Strategy Change Capital One Financial’s (COF) Narrative

Monumental Sports & Entertainment recently announced a 20-year extension of Capital One’s naming rights for the reimagined Capital One Arena in Washington, D.C., tied to a more than US$1.00 billion multi-phase transformation scheduled to be completed before the 2027–28 NBA and NHL seasons. The deal deepens Capital One’s presence in live sports and entertainment, using exclusive arena benefits for cardholders to strengthen brand engagement and everyday card usage. Now we’ll examine how this...
NYSE:CC
NYSE:CCChemicals

Chemours (CC) On Results And Data Center Push Has Value Back In Focus

Chemours (CC) has been in focus after a cluster of updates that matter for stockholders. The company reported fresh quarterly results, issued guidance, affirmed its dividend, and launched new low GWP refrigerants for data center cooling. See our latest analysis for Chemours. Chemours shares trade at US$15.24 after a recent 1-day share price return of 2.97% and 7-day share price return of 4.46%, although the 90-day share price return is down 38.70%, while the 5-year total shareholder return...
NYSE:SOLV
NYSE:SOLVMedical Equipment

Should Solventum’s (SOLV) Activist-Driven Asset Sales and HIS Separation Shift Its Capital Allocation Playbook?

Solventum Corp. recently reported second-quarter 2026 results showing slightly higher revenue and net income year on year, while also confirming that sustained pressure from activist investor Trian Fund Management drove both its earlier US$4.10 billion purification and filtration sale and its newly announced plan to separate the Health Information Systems business via options such as a spin-off or merger. At the same time, management reiterated its focus on disciplined tuck-in acquisitions...
NYSE:UNP
NYSE:UNPTransportation

Union Pacific (UNP) Stock Looks Reasonable On Cash Flow While Earnings Suggest More

Union Pacific stock has delivered a 46.3% total return over the past 5 years, and at around US$293.73 the question now is whether that strength still lines up with what the valuation work is saying. The Discounted Cash Flow (DCF) intrinsic value estimate points to a roughly fair price, while the earnings multiple view screens the stock as undervalued. Over 5 years, a 46.3% return suggests Union Pacific has already rewarded patient shareholders, so any new position may rely more heavily on...
NYSE:MMM
NYSE:MMMIndustrials

Is 3M (MMM) Fully Priced As Legal Risks Keep Building?

3M (MMM) is back under legal scrutiny after a Harris County jury ordered the company to pay US$61.5 million to Houston homeowners affected by the 2020 Watson Grinding & Manufacturing explosion. See our latest analysis for 3M. Against this legal backdrop, 3M’s momentum in the market has been strong, with a 30 day share price return of 16.54% and a 3 year total shareholder return of 139.31%. This suggests investors are weighing ongoing litigation against the company’s earnings profile and...
NYSE:CYD
NYSE:CYDMachinery

China Yuchai International (CYD) Could Be 31% Undervalued Following Strong Half Year Earnings

China Yuchai International (NYSE:CYD) is back in focus after its half year 2026 results showed sales of CNY 14,666.43 million and net income of CNY 560.6 million, alongside higher earnings per share. See our latest analysis for China Yuchai International. At a share price of US$46.93, China Yuchai International has posted a 26.77% year to date share price return and a 63.07% total shareholder return over the past year. The 3 year total shareholder return of more than 3x suggests longer term...
NasdaqGS:NFLX
NasdaqGS:NFLXEntertainment

Netflix (NFLX) Draws Ackman Back As Pershing Square Opens A New Position

Bill Ackman's Pershing Square returned to Netflix (NasdaqGS:NFLX) with a new equity position after previously exiting the stock at a loss. The move marks a renewed conviction in Netflix's long term outlook from a high profile institutional investor. Pershing Square's re entry arrives after its prior exit, which drew attention because of the fund's earlier loss and public commentary on the position. The decision may influence how other institutional investors assess Netflix's competitive...
NYSE:NEE
NYSE:NEEElectric Utilities

How Investors Are Reacting To NextEra Energy (NEE) Government-Backed Gas Buildout And Dividend Declaration

NextEra Energy recently declared a regular quarterly common stock dividend of US$0.6232 per share, payable on September 15, 2026, to shareholders of record as of August 28, 2026. The company also finalized funding agreements with the U.S. Department of Commerce and the Government of Japan to develop up to 10 gigawatts of natural gas-fired generation in Texas and Pennsylvania, marking a significant expansion of its conventional power footprint alongside its established renewables...
NasdaqGM:SOUN
NasdaqGM:SOUNSoftware

SoundHound AI (SOUN) Stock Looks Fully Priced Despite Strong 3 Year Returns

SoundHound AI stock has delivered a very large 3 year gain, yet the broader valuation checks and recent share price weakness suggest the current level may not be a clear bargain. With the stock still working through a sharp 1 year decline and a low value score, investors are weighing how much of the story is already reflected in today’s price. SoundHound AI has returned about 210% over the past 3 years, which puts a lot of focus on whether that performance has already been priced in. The...
NYSE:BAX
NYSE:BAXMedical Equipment

Baxter International (BAX) On Earnings Beat And Higher Guidance Has Fair Value Back In Focus

Baxter International (BAX) is back in focus after its latest earnings report showed higher quarterly sales and net income compared with last year, along with updated full year 2026 sales growth guidance of 3% to 4%. See our latest analysis for Baxter International. Baxter International’s share price has risen strongly in recent months, with a 30 day share price return of 19.41% and a 90 day share price return of 51.57%, even though the 5 year total shareholder return is down 60.38%. The...
NYSE:RMD
NYSE:RMDMedical Equipment

How Investors May Respond To ResMed (RMD) Dividend Hike And Ventilator Recall Headwinds

In early August 2026, ResMed Inc. reported higher fourth-quarter and full-year sales and earnings, lifted its quarterly dividend to US$0.66 per share, and confirmed completion of a US$1.40 billion buyback program that has retired about 7.92% of its shares since 2014. At the same time, management flagged a softer outlook tied to suspended ventilator sales after an FDA Class 1 recall, putting more emphasis on how resilient its broader sleep-health and digital platforms can be in supporting...
NYSE:EIX
NYSE:EIXElectric Utilities

Edison International (EIX) Stock Looks Cheap On Earnings But Strong Returns Raise Questions

Edison International stock has delivered a 50.1% return over the past five years, yet the broader valuation checks currently lean toward the shares looking inexpensive rather than stretched. Recent wildfire related headlines and legal developments sit in the background, so the key question for investors is whether the recent price around US$69.40 still offers value. A 50.1% return over five years suggests Edison International has already rewarded patient shareholders, so any fresh position...
NYSE:CF
NYSE:CFChemicals

Is CF Industries Holdings (CF) Undervalued Following Its Second Quarter 2026 Earnings?

CF Industries Holdings (CF) drew investor attention after reporting second quarter 2026 earnings that included US$2,222 million in sales and US$727 million in net income, along with a completed US$500 million share repurchase program. See our latest analysis for CF Industries Holdings. CF Industries Holdings shares trade at US$120.01, with a 1-day share price return of 1.88% and year to date share price return of 49.77%. The 5-year total shareholder return of 189.69% points to stronger long...
NYSE:SHAK
NYSE:SHAKHospitality

Shake Shack (SHAK) Stock Still Looks Expensive On Q2 Growth And Openings

Shake Shack stock has fallen 32.6% over the past year, yet the current price still screens as expensive on both an intrinsic value estimate using a Discounted Cash Flow (DCF) approach and on market multiples, which leaves investors questioning how much upside is already reflected in today’s valuation. Over the past 12 months the share price is down 32.6%, which means recent buyers have faced a material drawdown despite some shorter term rebounds. Recent revenue growth and new restaurant...
NYSE:BNL
NYSE:BNLREITs

Is Broadstone Net Lease (BNL) Cheap Following Its $225.5 Million Share Offering?

Broadstone Net Lease (BNL) recently completed a follow-on equity offering, issuing 11,000,000 common shares at approximately $20.50 each to raise about $225.5 million. This move directly affects ownership dilution and capital structure. See our latest analysis for Broadstone Net Lease. Broadstone Net Lease shares trade at US$21.07, with a 90 day share price return of 6.63% and a year to date share price return of 20.68%. The 1 year total shareholder return of 34.03% and 3 year total...